Literature DB >> 12726791

Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up.

Michael Gossop1, John Marsden, Duncan Stewart, Tara Kidd.   

Abstract

This paper investigates changes in injecting and shared use of needles and syringes among 732 drug misusers recruited to residential and community treatment programmes as part of the National Treatment Outcome Research Study (NTORS). Specifically, it investigates whether reductions in these behaviours were due to a move away from injecting among drug users or whether they could be accounted for by drug users becoming abstinent. Injecting and sharing of injecting equipment were substantially reduced after treatment. Outcomes were due to reduced sharing among injectors, reduced injecting among continuing users and to users becoming abstinent. Clients from residential programmes were more likely to be abstinent at follow-up: methadone clients were more likely to be injecting but not sharing. Abstinence and intermediate risk reduction outcomes were achieved by many drug injectors from both treatment settings. Both outcomes confer benefits, though the benefits of abstinence are greater. Users who were injectors at intake but who had stopped injecting at follow-up consistently achieved superior outcomes across a range of problem behaviours.

Entities:  

Mesh:

Year:  2003        PMID: 12726791     DOI: 10.1016/s0306-4603(01)00279-9

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  6 in total

1.  Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.

Authors:  Cheryl Teruya; Robert P Schwartz; Shannon Gwin Mitchell; Albert L Hasson; Christie Thomas; Samantha H Buoncristiani; Yih-Ing Hser; Katharina Wiest; Allan J Cohen; Naomi Glick; Petra Jacobs; Paul McLaughlin; Walter Ling
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

2.  [Treatment retention and evolution of clientele in a low threshold methadone substitution treatment program in Montreal].

Authors:  Michel Perreault; Marie-Christine Héroux; Noé Djawn White; Pierre Lauzon; Céline Mercier; Michel Rousseau
Journal:  Can J Public Health       Date:  2007 Jan-Feb

Review 3.  Prevention of HIV infection among injection drug users in resource-limited settings.

Authors:  David Vlahov; Angela M Robertson; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

Review 4.  Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?

Authors:  Maria Paz Garcia-Portilla; Maria Teresa Bobes-Bascaran; Maria Teresa Bascaran; Pilar Alejandra Saiz; Julio Bobes
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

5.  High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia.

Authors:  Shelly Iskandar; Diba Basar; Teddy Hidayat; Ike M P Siregar; Lucas Pinxten; Reinout van Crevel; Andre J A M Van der Ven; Cor A J De Jong
Journal:  BMC Public Health       Date:  2010-08-10       Impact factor: 3.295

6.  Character pathology and neuropsychological test performance in remitted opiate dependence.

Authors:  James M Prosser; Daniel Eisenberg; Emily E Davey; Matthew Steinfeld; Lisa J Cohen; Edythe D London; Igor I Galynker
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.